Han-Zhu Qian1, Yifei Hu, James G Carlucci, Lu Yin, Xiangwei Li, Anna R Giuliano, Dongliang Li, Lei Gao, Yiming Shao, Sten H Vermund. 1. From the *Vanderbilt Institute for Global Health, Vanderbilt University School of Medicine, †Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN; ‡Department of Child and Adolescent Health and Maternal Care, School of Public Health, Capital Medical University, Beijing, China; §Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN; ¶Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China; ∥Center for Infection Research in Cancer, Moffitt Cancer Center, Tampa, FL; **Chaoyang Center for Disease Control and Prevention; and ††State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China.
Abstract
BACKGROUND: Little is known about human papillomavirus (HPV) infection and genotypes when considering both anatomic site and human immunodeficiency virus (HIV) status among men who have sex with men (MSM) in low- and middle-income countries. METHODS: A cross-sectional study was conducted among MSM in Beijing, China. HIV serostatus was determined, and genital and anal HPV genotyping were performed from respective swabs. RESULTS: Of 1155 MSM, 817 (70.7%) had testing for genital (611; 52.9%) and/or anal (671; 58.1%) HPV. Preference for insertive anal sex (adjusted odds ratio [aOR], 2.60; 95% confidence interval [CI], 1.42-4.75) and syphilis (aOR, 1.50; 95% CI, 1.01-2.23) were associated with genital HPV. Inconsistent condom use during receptive anal sex (aOR, 1.82; 95% CI, 1.17-2.84), and HIV seropositivity (aOR, 2.90; 95% CI, 1.91-4.42) were associated with anal HPV. Among 465 (40.3%) MSM with specimens from both anatomic sites, anal HPV (68%) was more common than genital HPV (37.8%). Prevalence of anal HPV was higher among HIV-infected than uninfected MSM (P < 0.01). Some oncogenic HPV types were more commonly found at the anal site of HIV-infected MSM (P < 0.01). CONCLUSIONS: Human papillomavirus is highly prevalent among Chinese MSM. Anal HPV was more common than genital HPV, and HIV seropositivity was associated with oncogenic HPV types at the anal site.
BACKGROUND: Little is known about humanpapillomavirus (HPV) infection and genotypes when considering both anatomic site and human immunodeficiency virus (HIV) status among men who have sex with men (MSM) in low- and middle-income countries. METHODS: A cross-sectional study was conducted among MSM in Beijing, China. HIV serostatus was determined, and genital and anal HPV genotyping were performed from respective swabs. RESULTS: Of 1155 MSM, 817 (70.7%) had testing for genital (611; 52.9%) and/or anal (671; 58.1%) HPV. Preference for insertive anal sex (adjusted odds ratio [aOR], 2.60; 95% confidence interval [CI], 1.42-4.75) and syphilis (aOR, 1.50; 95% CI, 1.01-2.23) were associated with genital HPV. Inconsistent condom use during receptive anal sex (aOR, 1.82; 95% CI, 1.17-2.84), and HIV seropositivity (aOR, 2.90; 95% CI, 1.91-4.42) were associated with anal HPV. Among 465 (40.3%) MSM with specimens from both anatomic sites, anal HPV (68%) was more common than genital HPV (37.8%). Prevalence of anal HPV was higher among HIV-infected than uninfected MSM (P < 0.01). Some oncogenic HPV types were more commonly found at the anal site of HIV-infected MSM (P < 0.01). CONCLUSIONS:Human papillomavirus is highly prevalent among Chinese MSM. Anal HPV was more common than genital HPV, and HIV seropositivity was associated with oncogenic HPV types at the anal site.
Authors: Chris Beyrer; Stefan D Baral; Chris Collins; Eugene T Richardson; Patrick S Sullivan; Jorge Sanchez; Gift Trapence; Elly Katabira; Michel Kazatchkine; Owen Ryan; Andrea L Wirtz; Kenneth H Mayer Journal: Lancet Date: 2016-07-09 Impact factor: 79.321
Authors: Eileen F Dunne; Carrie M Nielson; Katherine M Stone; Lauri E Markowitz; Anna R Giuliano Journal: J Infect Dis Date: 2006-09-12 Impact factor: 5.226
Authors: Guillem Sirera; Sebastià Videla; Marta Piñol; Mari P Cañadas; Mariona Llatjos; Angel L Ballesteros; Francisco García-Cuyás; Eva Castellá; Rosa Guerola; Cristina Tural; Celestino Rey-Joly; Bonaventura Clotet Journal: AIDS Date: 2006-05-12 Impact factor: 4.177
Authors: Fleur van Aar; Sofie H Mooij; Marianne A B van der Sande; Arjen G C L Speksnijder; Ineke G Stolte; Chris J L M Meijer; Dominique W M Verhagen; Audrey J King; Henry J C de Vries; Maarten F Schim van der Loeff Journal: AIDS Date: 2013-11-28 Impact factor: 4.177
Authors: Hugo De Vuyst; Gary M Clifford; Maria Claudia Nascimento; Margaret M Madeleine; Silvia Franceschi Journal: Int J Cancer Date: 2009-04-01 Impact factor: 7.396
Authors: Alejandra J Portillo-Romero; Betania Allen-Leigh; Alan G Nyitray; Martha Carnalla; Jorge Salmerón; Leith León-Maldonado; Elsa Yunes; Leonor Rivera; Carlos Magis-Rodríguez; Galileo Vargas; Anna R Giuliano; Eiberth A Esquivel-Ocampo; Eduardo Lazcano-Ponce Journal: Transgend Health Date: 2021-12-02